Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Response to HSPPC-96 is not affected by cytokines in advanced melanoma patients

Sep. 22, 2005

Ticilimumab shows a favorable safety profile in advanced melanoma patients

Sep. 21, 2005

Viventia Biotech receives FDA approval to begin phase II Proxinium trials

Sep. 21, 2005

Preliminary phase I data on VX-001 immunotherapy in cancer patients

Sep. 20, 2005

Dendreon plans Provenge BLA filing

Sep. 19, 2005

Adjuvant trastuzumab increases survival in early-stage breast cancer

Sep. 19, 2005

huN901-DM1 enters clinical testing for multiple myeloma

Sep. 9, 2005

Avax files IND for phase I/II NSCLC study of AC Vaccine Therapeutic

Sep. 9, 2005

Phase I data on the effects of SB-485232 in renal cell carcinoma and multiple myeloma

Sep. 6, 2005

Galiximab demonstrates favorable safety profile in follicular lymphoma patients

Sep. 5, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...